CDT Equity Inc. (CDT)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- -39,224,000
- Operating income
- -36,757,000
- Earnings per share
- -1,177.89
- R&D expense
- 5,054,000
Growth and profitability
- Return on assets
- -694.23
Balance sheet
- Total assets
- 5,650,000
- Total liabilities
- 12,820,000
- Shareholders' equity
- -7,170,000
- Cash and equivalents
- 1,509,000
- Current ratio
- 0.34
Cash flow and ratios
- Operating cash flow
- -15,555,000
Shareholder returns
- Share buybacks
- 106,000
- Shares outstanding
- 786,670
Company information
- Headquarters
- Naples, FL
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
CDT Equity Inc. trades on NASDAQ under the ticker symbol CDT. This page brings together its price chart, company profile, key financial figures and technical indicators.